Domov › Rak dojke › Florida › Miami
Klinične študije za Rak dojke v Miami, FL
42 študij za Rak dojke išče udeležence na lokacijah v Miami in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Vključevanje udeležencevFaza 3
- Dwoskin Proton Therapy Center, Miami
- Miami Cancer Institute, Miami
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Vključevanje udeležencevFaza 3
- Miami Cancer Institute, Miami
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Miami
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- Sylvester Comprehensive Cancer Center, Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Vključevanje udeležencev
- Werheim Cancer Institute, Miami
Precise Oncology Interventions in Nutrition and Training (OnPoint)
Vključevanje udeležencevVabljeni zdravi prostovoljci
- University of Miami, Miami
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Vključevanje udeležencevVabljeni zdravi prostovoljci
- TopLine MD Alliance, Miami
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Vključevanje udeležencevFaza 2
- Baptist Alliance Miami Cancer Institute, Miami
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- University of Miami (Data Collection Only), Miami
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Miami Cancer Institute at Baptist Health Inc., Miami
- University of Miami, Miami
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- University of Miami, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- University of Miami, Miami
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Vključevanje udeležencevFaza 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Vključevanje udeležencevFaza 1/2
- Sylvester Comprehensive Cancer Center, Miami
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- University Of Miami-SCCC-Miami, Miami
- University of Miami_SCCC - Kendall, Miami
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Vključevanje udeležencevFaza 2
- Miami Cancer Institute/Baptist Hospital of Miami, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
Vključevanje udeležencevFaza 2
- Baptist Health Herbert Wertheim Cancer Institute, Miami
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Vključevanje udeležencevFaza 3
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Vključevanje udeležencevFaza 2
- Miami Baptist Cancer Institute/, Miami
SABER Study for Selected Early Stage Breast Cancer
Vključevanje udeležencev
- University of Miami, Miami
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Vključevanje udeležencevFaza 2
- University of Miami Hospital and Clinics, Miami
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Vključevanje udeležencevFaza 3
- Miami Cancer Institute, Miami
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
Vključevanje udeležencevFaza 3
- Baptist Health South Florida, Miami
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- University of Miami, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Vključevanje udeležencevFaza 2
- Miami Cancer Institute at Baptist Health (Kendall), Miami
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Vključevanje udeležencevFaza 1/2
- Miami Cancer Institute at Baptist Health, Miami
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
Vključevanje udeležencev
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Vključevanje udeležencevFaza 2
- Baptist Alliance - McI, Miami
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Vključevanje udeležencev
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Miami Cancer Institute, Miami
Breast Re-irradiation After Second Ipsilateral Lumpectomy
Vključevanje udeležencev
- Miami Cancer Institute at Baptist Health, Inc., Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Miami
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Vključevanje udeležencevOpazovalna študija
- Sylvester Comprehensive Cancer Center - University of Miami, Miami
- Miami Cancer Institute at Baptist Health, Inc, Miami
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- AP Medical Research, Miami
Študije za Rak dojke v drugih mestih
- New York City, NY134 študij
- Houston, TX126 študij
- Boston, MA111 študij
- Nashville, TN80 študij
- Los Angeles, CA72 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Durham, NC63 študij
- Queens, NY63 študij
- Chicago, IL58 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Miami
- Rak (vse vrste)36 študij
- Nemalicelični pljučni rak31 študij
- Rak prostate27 študij
- Debelost27 študij
- Akutna mieločna levkemija24 študij
- Metastatski rak24 študij
- Rak jajčnikov23 študij
- Prekomerna telesna teža23 študij
- Množni mielom21 študij
- Ulcerativni kolitis21 študij
- Alzheimerjeva bolezen20 študij
- Rak pljuč20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.